Outbreak of Infections with VIM-Positive <i>Proteus mirabilis</i> in a Hospital in Zagreb

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background/objectives: Proteus mirabilis is a frequent causative agent of urinary and wound in-fections in both community and hospital setting. It develops resistance to expanded-spectrum cephalosporins (ESC) due to the production of extended-spectrum β-lactamases (ESBLs) or plasmid-mediated AmpC β-lactamases (p-AmpC). Recently, carbapenem resistant isolates of P. mirabilis emerged due to production of carbapenemases, mostly belonging to Ambler class B and D. Here we report an outbreak of infections due to carbapenem-resistant P. mirabilis ob-served in a psychiatric hospital in Zagreb, Croatia. The characteristics of ESBL and car-bapenemase produced by P. mirabilis associated with an outbreak were analyzed. Material and methods: The antibiotic susceptibility testing was performed by disk-diffusion and broth dilution method. Double disk synergy test (DDST) and inhibitor- based test with clavulanic and phenylboronic acid were applied to screen for ESBLs and p-AmpC, respectively. Carbapenemases were screened by modified Hodge test (MHT) while carbapenem hydrolysis was investigated by CIM and eCIM test. The nature of ESBL, carbapenemases, and fluoroquin-olone resistance determinants was investigated by PCR. Transferability of cefotaxime and imipenem resistance was determined by conjugation. Plasmids were characterized by PCR-based replicon typing. Selected isolates were subjected to molecular characterization of re-sistome by the Interarray Carba Resist Kit and whole genome sequencing (WGS) Results: In total, 20 isolates were collected and analyzed. All isolates exhibited resistance to amoxicillin alone and combined with clavulanic acid, cefuroxime, ceftazidime, cefotaxime, ceftriaxone, cefepime, imipenem, ceftazidime-avibactam, ceftolozane-tazobactam, gentamicin, amikacin and ciprofloxacin. There was uniform susceptibility to ertapenem, meropenem and cefiderocol. DDST and combined disk test with clavulanic acid tested positive indicating pro-duction of an ESBL. MHT was negative in all isolates while CIM showed moderate sensitivity but only with imipenem as indicator disk. E-CIM tested positive in all CIM positive isolates, consistent with an MBL. PCR and sequencing of selected amplicons identified VIM-1 and VIM-4. The Interarray Carba Resist Kit and whole genome sequencing (WGS) identified β-lactam re-sistance genes: blaVIM, blaCTX-M-15, and blaTEM genes, aminoglycoside resistance genes: aac(3)-IId, aph(6)-Id, aph(3'')-Ib, aadA1, armA, and aac(6')-IIc, and resistance genes for sulphonamides sul1 and sul2, trimethoprim dfr1, chloramfenicol cat and tetracycline tetJ. Conclusions: The study revealed epidemic spread of carbapenemase producing P. mirabilis in two wards in a psychiatric hospital. This is the first report of VIM producing P. mirabilis in Croatia.

Article activity feed